TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an update.
Pharmaxis Ltd has released its annual report for the year ending June 30, 2025. The report includes comprehensive financial statements and disclosures, providing insights into the company’s financial health and operational performance. This release is crucial for stakeholders to assess the company’s market position and future prospects.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
For an in-depth examination of SNT stock, go to TipRanks’ Overview page.